E. Norriton, Penn., April 9, 2019.
Eleven companies achieved the highest honors in TGaS®Advisors’ second annual search for the biopharmaceutical industry’s Best of Benchmark, or “BoBs,” with 15 awards presented across 12 categories. The BoBs, awarded for commercial excellence, are based on the firm’s benchmarking of large, midsize and emerging life sciences companies. The BoBs will be presented at a special awards ceremony on April 29, 2019, at the Renaissance Hotel Convention Center in Schaumburg, IL, where TGaS, a division…
Read Now
E. Norriton, Penn., March 26, 2019
TGaS® Advisors, a division of Trinity, announced that Tracy L. Mills was promoted to vice president, Executive Commercial Operations (ECOS) practice, for the benchmarking and advisory services firm. She joins a senior ECOS management team, helping companies optimize consolidation, integration, transformation and other major initiatives across the commercial sector and leverage the benefits of high-level benchmarking. Mills previously worked with the company’s Emerging Life Sciences Network (elsN), where she provided consulting and advisory services…
Read Now
Trinity, a leading global life sciences consulting firm, today announced it will be a Program Partner for the “Gene Therapy For Rare Disorders” conference taking place on March 26-28 in Boston. Trinity’s Krista Perry will be presenting at the conference to highlight Trinity’s continued involvement supporting companies commercializing products for rare diseases, including our significant experience with gene and cell therapies. With Trinity as a key sponsor, this event brings together 450+ industry leaders and experts from innovative biotechs, large…
Read Now
Trinity, a leading global life sciences consulting firm, announced that it will be presenting two posters at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting on March 25-28 in San Diego. This event brings together national leaders to discuss the latest developments on evidence- and value-based strategies to increase patient access to affordable medicine.
Trinity’s AMCP presentations include: 1) A medical chart review quantifying the “Unmet Needs in the Diagnosis and Treatment of Women With Hypoactive Sexual Desire Disorder”…
Read Now
E. Norriton, Penn., Jan. 8, 2019
TGaS® Advisors, a division of Trinity, has announced four new additions to the benchmarking and advisory services firm. Dmitry Kublanov is vice president, Pricing, Contracting & Analytics, and Jerry Luciano is vice president, Omnichannel Marketing (formerly Digital and Multichannel Marketing). Learning & Development added Steve Regan as executive director and Kristin Scott as director.
Kublanov comes to TGaS with more than 20 years in Managed Markets pricing and reimbursement, contract management system integration, deal analytics…
Read Now
Therapies for breast cancer, multiple myeloma, and HIV ranked the highest across audit of commercial performance, therapeutic value, and R&D complexity.
WALTHAM, Mass. – December 17, 2018 — Trinity, a leading global life science consulting firm, today announced the findings of its third annual Trinity Drug Index which assessed 57 novel drugs approved by the FDA in 2015. The index ranks drug performance against three categories: commercial performance, therapeutic value and R&D complexity, assigning each drug a score in those…
Read Now
Leading global life sciences consulting firm Trinity has been named to Consulting Magazine’s 2018 lists of “Best Small Firms to Work For” as well as the magazine’s list of “Fastest Growing Firms” for the third consecutive year.
Consulting Magazine’s annual ranking of the industry’s “Best Firms to Work For” is based on employee survey responses regarding six areas of employee satisfaction including culture, career development, work/life balance, client engagement, compensation and benefits, and firm leadership. Consulting Magazine’s list of “Fastest…
Read Now
Experts from Trinity have published a bylined article in In Vivo. The article, titled, “You May Be Making These Drug Forecasting Mistakes,” breaks down the most common missteps in forecasting and highlights how to design and use the best models for the most accurate outcomes. In the article, Alex Chiang, Principal, and Adrian Watson, Senior Manager, Modeling and Analytics, discuss the top 10 most common drug forecasting errors, which fall into three broad categories: model design issues, model maintenance issues,…
Read Now
Waltham, MA—Global life sciences consulting firm Trinity today announced it will present the panel discussion, “Tissue-Agnostic Cancer Drug Development: An Emerging Paradigm Shift?” along with Pfizer and the Healthcare Businesswomen’s Association (HBA). The event, featuring perspectives from clinical, commercial, regulatory and market access experts, will take place at Pfizer’s headquarters in New York City on October 23, 2018 from 5:30-8 pm.
Cancer treatment has made significant strides toward the promise of personalized medicine in recent years. With Keytruda’s tissue-agnostic MSI-H/dMMR…
Read Now
Trinity issued a paper on asset valuation that explores the common methodologies for the valuation of pharma and biotech assets and highlights key considerations for capturing asset-specific nuances and accurately reflecting value.…
Read Now